Firstly, both our data and Giulio Spagnoli group’s data found that phenotype of peripheral blood CD11b+CD16+myeloid cells had no difference between healthy donors and CRC patients without capecitabine therapy (Fig. S1F and G). The gene discussed is ITGAM; the disease is colorectal carcinoma.